Issue 3, 2011

Repairing faulty genes by aminoglycosides: Identification of new pharmacophore with enhanced suppression of disease-causing nonsense mutations

Abstract

New pseudo-trisaccharide derivatives of aminoglycosides containing a chiral methyl group at the side-chain of the ribosamine ring (ring III) were designed, synthesized and their ability to readthrough nonsense mutations was examined in both in vitro and ex vivo systems, along with toxicity tests. Novel lead structures, exhibiting significantly reduced cell toxicity, enhanced specificity to eukaryotic cytoplasmic ribosome, and superior readthrough efficiency compared with those of gentamicin, were discovered. The comparative benefit of new leads was demonstrated in six different nonsense DNA-constructs underling the genetic diseases cystic fibrosis, Duchenne muscular dystrophy, Usher syndrome and Hurler syndrome.

Graphical abstract: Repairing faulty genes by aminoglycosides: Identification of new pharmacophore with enhanced suppression of disease-causing nonsense mutations

Supplementary files

Article information

Article type
Concise Article
Submitted
01 Nov 2010
Accepted
09 Dec 2010
First published
14 Jan 2011

Med. Chem. Commun., 2011,2, 165-171

Repairing faulty genes by aminoglycosides: Identification of new pharmacophore with enhanced suppression of disease-causing nonsense mutations

J. Kandasamy, D. Atia-Glikin, V. Belakhov and T. Baasov, Med. Chem. Commun., 2011, 2, 165 DOI: 10.1039/C0MD00195C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements